Sierra Summits gets the word out: sunburn still a risk in cooler seasons
RENO Skin care company Sierra Summits, which makes High Altitude Adventure Sunblock, is reminding consumers of the importance of using sunblock in the fall and winter.
“During the winter, even cautious outdoor enthusiasts may unknowingly put their skin at risk by leaving it unprotected or under-protected,” sated Sierra Summits’ founder and chief executive officer Jennifer Rice. “Cool weather may lull people into thinking they don?t need sunscreen when, in fact, UV rays are intensified by now and high altitudes.”
According to the company, snow reflects 80 percent of UV rays and UV intensity increases by 10 percent every 1,000-foot increase in elevation. In the mountains or snow, skin can burn more severely in less time. The American Academy of Dermatology recommends applying sunscreen when in the sun for more than 20 minutes.
Seeing a need in the marketplace for an affordable formula that protects skin under intense, high-altitude conditions, Rice designed the Sierra Summits High Altitude Adventure Sunblock. The product promises to offer multiple hour, broad spectrum, high-altitude and photostable protection against UVB and UVA rays. The product is priced at $7.95 for a 1.5-ounce tube and $25 for an 8-ounce tube.
Alberto-Culver obtains Noxema line from P&G
MELROSE PLACE, Ill. Alberto-Culver has completed its acquisition of the worldwide rights and trademarks to the Noxzema skin care brand from Procter & Gamble.
The transaction includes the existing business in the United States, Canada and portions of Latin America. P&G will continue to operate its existing Noxzema shave care, antiperspirant/deodorant, body wash and body soap business in portions of Western Europe.
Alberto-Culver’s portfolio of beauty products includes TRESemme, Alberto V05, Nexxus and St. Ives.
Physicians Formula buys back common stock, evaluates price per share
AZUSA, Calif. Physicians Formula’s board authorized in September the repurchase up to $10 million of the company’s outstanding common stock.
The company had approximately 14,096,227 shares of common stock outstanding as of Aug. 8. In connection with the repurchase program, the company also announced that it has adopted a written trading plan under Rule 10b5-1 under the Securities Exchange Act of 1934, to facilitate the repurchase of shares of common stock under the repurchase program.
In addition, the beauty company has entered into an amendment to its existing senior credit agreement with Union Bank of California, N.A. to permit borrowings under the revolving credit facility to fund the repurchase program.
“Our board believes that at the current stock price, our stock is undervalued based on many criteria, including the long-term growth prospects for the company, and that the repurchase program is an effective means to increase shareholder value,” stated Ingrid Jackel, chief executive officer of Physicians Formula. “Our board also believes that we are well positioned to increase long-term shareholder value by growing our business through product innovation and differentiation, and by providing strong support for existing and new products through creative promotional activities.”